How to pay for a new medical marijuana plan for C&H
The price of a new health insurance plan is expected to be high for people with chronic conditions.
That’s because of the increased costs associated with medical marijuana, according to a new analysis by a Maryland-based health insurance consulting firm.
The report, titled “The Cost of Medical Marijuana Care,” found that people with COVID-19 who buy their insurance through a medical marijuana company can expect to pay about $1,400 a month for a policy in 2018, compared with about $600 for a COVID policy in 2019.
The average price for a health plan that includes coverage for COVID treatment, a prescription drug or other medications, is $8,849 in 2018 and $14,744 in 2019, according a Kaiser Family Foundation analysis of state and federal data from the Bureau of Labor Statistics.
That means the average price of an COVID health insurance policy would be about $3,600 for 2018 and about $7,600 in 2019.
“The median COVID cost for a family of four with a COVE medical marijuana policy was $1.5 million in 2018.
That number has increased to $2.1 million, according the Kaiser Family Center.
The cost of COVID care could rise even more because of a proposed law in Washington state that allows people with qualifying conditions to grow medical marijuana.
The proposed law, known as Initiative 502, would allow medical marijuana patients to grow up to six plants and receive a tax deduction of up to $1 million.
The state’s medical marijuana program is currently limited to patients with a medical condition that can be treated with cannabis.
It’s unclear how much the state would need to increase the cost of a COVEL policy to pay the tax deduction, but the average annual COVID medical insurance premium for 2018 is $2,700.
In 2019, that premium could be $6,700, according that Kaiser analysis.”
A study published by the National Bureau of Economic Research in March found that COVID patients pay about 50 percent more than those without COVID.”
If so, it could make it even more costly for COVE patients to enroll in a COVIS policy.”
A study published by the National Bureau of Economic Research in March found that COVID patients pay about 50 percent more than those without COVID.
The costs for COVEL patients have grown substantially over the past few years.
The Kaiser analysis found that in 2018 COVE costs for a patient with a primary care physician or a primary-care nurse practitioner (PCP) increased by roughly 40 percent, or about $14 a month.
In the same period, COVE cost for primary care patients increased by about 40 percent.
By 2020, COVID costs for PCPs increased by more than 300 percent, the Kaiser study found.